The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018

LONDON, March 11, 2019 /PRNewswire/ --

The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027.

Download the full report: https://www.reportbuyer.com/product/5751937

Driving factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics.Whereas, the trend of the extensive set of molecular-based approaches positive impact on the growth of the market in the coming years.

However, high capital costs of metagenomics is anticipated to restrain the market growth.The extensive research for the microbial studies are being conducted to study the genetic make-up of the microorganisms.

The collection of the microbial sample collected from the environmental resources owes the huge diversity in their genes.The study have helped to discover antibiotics and are expected to assist more in the drug discovery in the coming future.

The current trend of the molecular-based approaches has enabled the field of the metagenomics to study the uncultured microorganisms. The metagenomics has also helped in the huge way for the clinical diagnostics and the clinical diagnostics is the current trend going on cross the world. Also the extensive research is been going-on currently for the environmental sectors. Also the metagenomics have potential to discover products for the biotechnology, agriculture biotechnology, food technology and others. The potential of the metagenomics in the pharmaceuticals owe to the large hopes for growth opportunities for the market players. Also the novel innovations from the market players are likely to discover the solutions for the chronic infectious diseases. The initial cost of the primary set up for the metagenomics is very high, however, the technological advancement and the efforts by the market leader such as Illumina Inc., Pacific Bioscience of California Inc., among the others are likely to meet this challenge. These market players are aggressively working to provide cost effective solutions for the metagenomics studies. The healthcare industry is likely to experience the positive outcomes in the coming future.
Global metagenomics market, based on the application was segmented into clinical diagnostics, drug discovery, and other applications. Clinical Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the forecast period. The metagenomics offers prodigious potential for the identification of uncultured microorganism that can be used to detect and diagnose infectious diseases and the genetic properties of the microorganism. Therefore, the segment held the largest market share of 47.9% for the application segment in the metagenomics market and is likely to dominate the market in coming forecast period.
Some of the major primary and secondary sources included in the report for the metagenomics market are Brazilian Microbiome Project, Centers for Disease Control and Prevention, Canada and Canadian Institutes of Health Research Institute of Infection and Immunity, Council of Scientific & Industrial Research, Department of Biotechnology, International Center for Biosaline Agriculture, Janssen Human Microbiome Institute, Joint Genome Institute, and others.

Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Download the full report: https://www.reportbuyer.com/product/5751937

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-global-metagenomics-market-is-expected-to-reach-us-314-3-mn-in-2027-from-us-165-8-in-2018--300810026.html

SOURCE ReportBuyer